NIH Human Embryonic Stem Cell Registry – Research Using …


CHB-1 (see details) 0001 On Hold ** George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-2 (see details) 0002 On Hold ** George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-3 (see details) 0003 On Hold ** George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-4 (see details) 0004 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-5 (see details) 0005 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-6 (see details) 0006 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-8 (see details) 0007 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-9 (see details) 0008 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-10 (see details) 0009 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-11 (see details) 0010 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 CHB-12 (see details) 0011 George Q. Daley, M.D., Ph.D. Children's Hospital Corporation 12/02/2009 RUES1 (see details) 0012 The Rockefeller University, Ali Brivanlou The Rockefeller University 12/02/2009 RUES2 (see details) 0013 The Rockefeller University, Ali Brivanlou The Rockefeller University 12/02/2009 HUES 1 (see details) 0014 HSCI iPS Core Harvard University 12/14/2009 HUES 2 (see details) 0015 HSCI iPS Core Harvard University 12/14/2009 HUES 3 (see details) 0016 HSCI iPS Core Harvard University 12/14/2009 HUES 4 (see details) 0017 HSCI iPS Core Harvard University 12/14/2009 HUES 5 (see details) 0018 HSCI iPS Core Harvard University 12/14/2009 HUES 6 (see details) 0019 HSCI iPS Core Harvard University 12/14/2009 HUES 7 (see details) 0020 HSCI iPS Core Harvard University 12/14/2009 HUES 8 (see details) 0021 HSCI iPS Core Harvard University 12/14/2009 HUES 9 (see details) 0022 HSCI iPS Core Harvard University 12/14/2009 HUES 10 (see details) 0023 HSCI iPS Core Harvard University 12/14/2009 HUES 11 (see details) 0024 HSCI iPS Core Harvard University 12/14/2009 HUES 12 (see details) 0025 HSCI iPS Core Harvard University 12/14/2009 HUES 13 (see details) 0026 HSCI iPS Core Harvard University 12/14/2009 HUES 14 (see details) 0027 HSCI iPS Core Harvard University 12/14/2009 HUES 15 (see details) 0028 HSCI iPS Core Harvard University 12/14/2009 HUES 16 (see details) 0029 HSCI iPS Core Harvard University 12/14/2009 HUES 17 (see details) 0030 HSCI iPS Core Harvard University 12/14/2009 HUES 18 (see details) 0031 HSCI iPS Core Harvard University 12/14/2009 HUES 19 (see details) 0032 HSCI iPS Core Harvard University 12/14/2009 HUES 20 (see details) 0033 HSCI iPS Core Harvard University 12/14/2009 HUES 21 (see details) 0034 HSCI iPS Core Harvard University 12/14/2009 HUES 22 (see details) 0035 HSCI iPS Core Harvard University 12/14/2009 HUES 23 (see details) 0036 HSCI iPS Core Harvard University 12/14/2009 HUES 24 (see details) 0037 HSCI iPS Core Harvard University 12/14/2009 HUES 26 (see details) 0038 HSCI iPS Core Harvard University 12/14/2009 HUES 27 (see details) 0039 HSCI iPS Core Harvard University 12/14/2009 HUES 28 (see details) 0040 HSCI iPS Core Harvard University 12/14/2009 CyT49 (see details) 0041 ViaCyte, Inc. 01/19/2010 RUES3 (see details) 0042 The Rockefeller University, Ali Brivanlou The Rockefeller University 01/19/2010 WA01 (H1) (see details) 0043 WiCell Research Institute WiCell Research Institute 01/29/2010 UCSF4 (see details) 0044 Susan Fisher University of California San Francisco 03/12/2010 NYUES1 (see details) 0045 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES2 (see details) 0046 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES3 (see details) 0047 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES4 (see details) 0048 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES5 (see details) 0049 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES6 (see details) 0050 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 NYUES7 (see details) 0051 Christoph Hansis, MD, PhD New York University School of Medicine 03/29/2010 MFS5; disease-specific mutation (see details) 0052 Eric Chiao Stanford University 04/27/2010 HUES 48 (see details) 0053 HSCI iPS Core Harvard University 04/27/2010 HUES 49 (see details) 0054 HSCI iPS Core Harvard University 04/27/2010 HUES 53 (see details) 0055 HSCI iPS Core Harvard University 04/27/2010 HUES 65 (see details) 0056 HSCI iPS Core Harvard University 04/27/2010 HUES 66 (see details) 0057 HSCI iPS Core Harvard University 04/27/2010 UCLA 1 (see details) 0058 Steven Peckman University of California, Los Angeles 04/27/2010 UCLA 2 (see details) 0059 Steven Peckman University of California, Los Angeles 04/27/2010 UCLA 3 (see details) 0060 Steven Peckman University of California, Los Angeles 04/27/2010 WA07 (H7) (see details) 0061 WiCell Research Institute WiCell Research Institute 04/27/2010 WA09 (H9) (see details) 0062 WiCell Research Institute WiCell Research Institute 04/27/2010 WA13 (H13) (see details) 0063 WiCell Research Institute WiCell Research Institute 04/27/2010 WA14 (H14) (see details) 0064 WiCell Research Institute WiCell Research Institute 04/27/2010 HUES 62 (see details) 0065 HSCI iPS Core Harvard University 06/03/2010 HUES 63 (see details) 0066 HSCI iPS Core Harvard University 06/03/2010 HUES 64 (see details) 0067 HSCI iPS Core Harvard University 06/03/2010 CT1 (see details) 0068 University of Connecticut Stem Cell Core UNIVERSITY OF CONNECTICUT SCH OF MED/DNT 06/21/2010 CT2 (see details) 0069 University of Connecticut Stem Cell Core UNIVERSITY OF CONNECTICUT SCH OF MED/DNT 06/21/2010 CT3 (see details) 0070 University of Connecticut Stem Cell Core UNIVERSITY OF CONNECTICUT SCH OF MED/DNT 06/21/2010 CT4 (see details) 0071 University of Connecticut Stem Cell Core UNIVERSITY OF CONNECTICUT SCH OF MED/DNT 06/21/2010 MA135 (see details) 0072 Advanced Cell Technology, Inc. Advanced Cell Technology, Inc. 06/21/2010 Endeavour-2 (see details) 0073 Kuldip Sidhu Stem Cell Laboratory, Faculty of medicine, University of New South Wales 06/21/2010 WIBR1 (see details) 0074 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 06/21/2010 WIBR2 (see details) 0075 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 06/21/2010 HUES 45 (see details) 0076 HSCI iPS Core Harvard University 09/28/2010 Shef 3 (see details) 0077 Centre for Stem Cell Biology University of Sheffield 11/17/2010 Shef 6 (see details) 0078 Centre for Stem Cell Biology University of Sheffield 11/17/2010 WIBR3 (see details) 0079 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 11/17/2010 WIBR4 (see details) 0080 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 11/17/2010 WIBR5 (see details) 0081 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 11/17/2010 WIBR6 (see details) 0082 Whitehead Institute for Biomedical Research/Maya Mitalipova Whitehead Institute for Biomedical Research 11/17/2010 BJNhem19 (see details) 0083 Jawaharlal Nehru Centre for Advanced Scientific Research Jawaharlal Nehru Centre for Advanced Scientific Research 12/17/2010 BJNhem20 (see details) 0084 Jawaharlal Nehru Centre for Advanced Scientific Research Jawaharlal Nehru Centre for Advanced Scientific Research 12/17/2010 SA001 (see details) 0085 Cellartis AB Cellartis AB 12/17/2010 SA002; abnormal karyotype (see details) 0086 Cellartis AB Cellartis AB 12/17/2010 UCLA 4 (see details) 0087 Steven Peckman University of California Los Angeles 02/03/2011 UCLA 5 (see details) 0088 Steven Peckman University of California Los Angeles 02/03/2011 UCLA 6 (see details) 0089 Steven Peckman University of California Los Angeles 02/03/2011 HUES PGD 13; disease-specific mutation (see details) 0090 Eggan Lab Harvard University 03/15/2011 HUES PGD 3; disease-specific mutation (see details) 0091 Eggan Lab Harvard University 03/15/2011 ESI-014 (see details) 0092 BioTime, Inc. 06/02/2011 ESI-017 (see details) 0093 BioTime, Inc. BioTime, Inc. 06/02/2011 HUES PGD 11; disease-specific mutation (see details) 0094 Eggan Lab Harvard University 06/07/2011 HUES PGD 12; disease-specific mutation (see details) 0095 Eggan Lab Harvard University 06/07/2011 WA15 (see details) 0096 WiCell Research Institute WiCell Research Institute 06/09/2011 WA16; disease-specific mutation/abnormal karyotype (see details) 0097 WiCell Research Institute WiCell Research Institute 06/09/2011 WA17 (see details) 0098 WiCell Research Institute WiCell Research Institute 06/09/2011 WA18 (see details) 0099 WiCell Research Institute WiCell Research Institute 06/09/2011 WA19 (see details) 0100 WiCell Research Institute WiCell Research Institute 06/09/2011 WA20 (see details) 0101 WiCell Research Institute WiCell Research Institute 06/09/2011 WA21 (see details) 0102 WiCell Research Institute WiCell Research Institute 06/09/2011 WA22 (see details) 0103 WiCell Research Institute WiCell Research Institute 06/09/2011 WA23 (see details) 0104 WiCell Research Institute WiCell Research Institute 06/09/2011 WA24 (see details) 0105 WiCell Research Institute WiCell Research Institute 06/09/2011 CSES2 (see details) 0106 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES4 (see details) 0107 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES7 (see details) 0108 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES8; abnormal karyotype (see details) 0109 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES11; abnormal karyotype (see details) 0110 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES12; abnormal karyotype (see details) 0111 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES13; abnormal karyotype (see details) 0112 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES14; abnormal karyotype (see details) 0113 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES15 (see details) 0114 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES17 (see details) 0115 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES19 (see details) 0116 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES20; abnormal karyotype (see details) 0117 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES21; abnormal karyotype (see details) 0118 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES22; abnormal karyotype (see details) 0119 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES23; abnormal karyotype (see details) 0120 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES24; abnormal karyotype (see details) 0121 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 CSES25 (see details) 0122 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 06/10/2011 HAD-C 100 (see details) 0123 Benjamin E. Reubinoff Hadassah Hebrew University Medical Center 06/16/2011 HAD-C 102 (see details) 0124 Benjamin E. Reubinoff Hadassah Hebrew University Medical Center 06/16/2011 HAD-C 106 (see details) 0125 Benjamin E. Reubinoff Hadassah Hebrew University Medical Center 06/16/2011 RNJ19; disease-specific mutation (see details) 0126 Reprogenetics, LLC Reprogenetics, LLC 06/16/2011 RNJ20; disease-specific mutation (see details) 0127 Reprogenetics, LLC Reprogenetics, LLC 06/16/2011 RNJ18; disease-specific mutation (see details) 0128 Reprogenetics, LLC Reprogenetics, LLC 06/16/2011 ESI-035 (see details) 0129 BioTime, Inc. BioTime, Inc. 08/18/2011 ESI-049 (see details) 0130 BioTime, Inc. BioTime, Inc. 08/18/2011 ESI-051 (see details) 0131 BioTime, Inc. BioTime, Inc. 08/18/2011 ESI-053 (see details) 0132 BioTime, Inc. BioTime, Inc. 08/18/2011 CSES5; abnormal karyotype (see details) 0133 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 09/27/2011 CSES6; abnormal karyotype (see details) 0134 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 09/27/2011 CSES18 (see details) 0135 Dhruv Sareen, Ph.D. Cedars-Sinai Medical Center 09/27/2011 HUES PGD 14; disease-specific mutation (see details) 0136 Eggan Lab Harvard University 10/11/2011 CA1 (see details) 0137 Andras Nagy Mt Sinai Hosp-Samuel Lunenfeld Research Institute 12/12/2011 CA2 (see details) 0138 Andras Nagy Mt Sinai Hosp-Samuel Lunenfeld Research Institute 12/12/2011 MEL-1 (see details) 0139 StemCore, Stem Cells Ltd University of Queensland 12/22/2011 MEL-2 (see details) 0140 StemCore, Stem Cells Ltd University of Queensland 12/22/2011 MEL-3 (see details) 0141 StemCore, Stem Cells Ltd University of Queensland 12/22/2011 MEL-4 (see details) 0142 StemCore, Stem Cells Ltd University of Queensland 12/22/2011 UCLA 7; disease-specific mutation/abnormal karyotype (see details) 0143 Steven Peckman University of California, Los Angeles 01/12/2012 UCLA 8 (see details) 0144 Steven Peckman University of California, Los Angeles 01/12/2012 UCLA 9 (see details) 0145 Steven Peckman University of California, Los Angeles 01/12/2012 UCLA 10 (see details) 0146 Steven Peckman University of California, Los Angeles 01/12/2012 UM4-6 (see details) 0147 Gary D. Smith, University of Michigan University of Michigan 02/02/2012 HUES PGD 1; disease-specific mutation (see details) 0148 Eggan Lab Harvard University 02/24/2012 HUES PGD 15; possible disease-specific mutation (see details) 0149 Eggan Lab Harvard University 02/24/2012 HUES PGD 16; disease-specific mutation (see details) 0150 Eggan Lab Harvard University 02/24/2012 GENEA002 (see details) 0151 Genea Biocells Genea Biocells 03/20/2012 GENEA048; abnormal karyotype (see details) 0152 Genea Biocells Genea Biocells 03/20/2012 UM11-1PGD; disease-specific mutation (see details) 0153 Gary D. Smith, University of Michigan University of Michigan 04/12/2012 UM9-1PGD; disease-specific mutation (see details) 0154 Gary D. Smith, University of Michigan University of Michigan 05/14/2012 UM38-2 PGD; disease-specific mutation (see details) 0155 Gary D. Smith, University of Michigan University of Michigan 05/14/2012 Elf1 (see details) 0156 University of Washington 05/15/2012 HUES 42 (see details) 0157 HSCI iPS Core Harvard University 05/31/2012 HUES 44 (see details) 0158 HSCI iPS Core Harvard University 05/31/2012 NMR-1 (see details) 0159 Rick A. Wetsel, Ph.D. University of Texas Hlth Sci Ctr Houston 05/31/2012 UM17-1 PGD; disease-specific mutation (see details) 0160 Gary D. Smith/University of Michigan University of Michigan 05/31/2012 UM15-4 PGD; disease-specific mutation (see details) 0161 University of Michigan, Gary D. Smith University of Michigan 05/31/2012 UM14-1 (see details) 0162 Gary D. Smith/University of Michigan University of Michigan 05/31/2012 UM14-2 (see details) 0163 Gary D. Smith/University of Michigan University of Michigan 05/31/2012 UM29-2 PGD; disease-specific mutation (see details) 0164 Gary D. Smith/University of Michigan University of Michigan 06/18/2012 UM29-3 PGD; disease-specific mutation (see details) 0165 Gary D. Smith/University of Michigan University of Michigan 06/18/2012 GENEA017; disease-specific mutation (see details) 0166 Genea Biocells Genea Biocells 06/20/2012 GENEA041; disease-specific mutation (see details) 0167 Genea Biocells Genea Biocells 06/20/2012 GENEA068; disease-specific mutation (see details) 0168 Genea Biocells Genea Biocells 06/20/2012 GENEA018; disease-specific mutation (see details) 0169 Genea Biocells Genea Biocells 06/20/2012 GENEA024; disease-specific mutation (see details) 0170 Genea Biocells Genea Biocells 06/20/2012 GENEA040; disease-specific mutation (see details) 0171 Genea Biocells Genea Biocells 06/20/2012 GENEA060; disease-specific mutation (see details) 0172 Genea Biocells Genea Biocells 06/20/2012 GENEA061; disease-specific mutation (see details) 0173 Genea Biocells Genea Biocells 06/20/2012 GENEA064; disease-specific mutation (see details) 0174 Genea Biocells Genea Biocells 06/20/2012 GENEA059; disease-specific mutation (see details) 0175 Genea Biocells Genea Biocells 07/09/2012 HUES 68 (see details) 0176 HSCI iPS Core Harvard University 07/09/2012 HUES 70 (see details) 0177 HSCI iPS Core Harvard University 07/09/2012 HUES 69 (see details) 0178 HSCI iPS Core Harvard University 08/07/2012 HUES PGD 10 (see details) 0179 Eggan Lab Harvard University 09/24/2012 GENEA046; disease-specific mutation (see details) 0180 Genea Biocells Genea Biocells 10/05/2012 GENEA069; disease-specific mutation (see details) 0181 Genea Biocells Genea Biocells 10/05/2012 GENEA070; disease-specific mutation (see details) 0182 Genea Biocells Genea Biocells 10/05/2012 GENEA049; disease-specific mutation (see details) 0183 Genea Biocells Genea Biocells 11/02/2012 GENEA050; disease-specific mutation (see details) 0184 Genea Biocells Genea Biocells 11/02/2012 UCLA 11 (see details) 0185 Steven Peckman University of California, Los Angeles 11/20/2012 UCLA 12 (see details) 0186 Steven Peckman University of California, Los Angeles 11/20/2012 GENEA062; disease-specific mutation (see details) 0187 Genea Biocells Genea Biocells 12/14/2012 GENEA063; disease-specific mutation (see details) 0188 Genea Biocells Genea Biocells 12/14/2012 GENEA066; disease-specific mutation (see details) 0189 Genea Biocells Genea Biocells 12/14/2012 GENEA067; disease-specific mutation (see details) 0190 Genea Biocells Genea Biocells 12/14/2012 GENEA071; disease-specific mutation (see details) 0191 Genea Biocells Genea Biocells 12/14/2012 GENEA072; disease-specific mutation (see details) 0192 Genea Biocells Genea Biocells 12/14/2012 GENEA073; disease-specific mutation (see details) 0193 Genea Biocells Genea Biocells 12/14/2012 GENEA074; disease-specific mutation (see details) 0194 Genea Biocells Genea Biocells 12/14/2012 HUES PGD 2; possible disease-specific mutation (see details) 0195 Eggan Lab Harvard University 12/14/2012 WA25 (see details) 0196 WiCell Research Institute WiCell Research Institute 12/14/2012 WA26 (see details) 0197 WiCell Research Institute WiCell Research Institute 12/14/2012 WA27 (see details) 0198 WiCell Research Institute WiCell Research Institute 12/14/2012 GENEA058; Disease-specific mutation (see details) 0199 Genea Biocells Genea Biocells 01/08/2013 GENEA065; Disease-specific mutation (see details) 0200 Genea Biocells Genea Biocells 01/08/2013 HS346 (see details) 0201 Karolinska Institute Karolinska Institute 03/18/2013 HS401 (see details) 0202 Karolinska Institute Karolinska Institute 03/18/2013 HS420 (see details) 0203 Karolinska Institute Karolinska Institute 03/18/2013 I3 (TE03) (see details) 0204 Technion R&D foundation Technion R&D Foundation 03/18/2013 I4 (TE04) (see details) 0205 Technion R&D foundation Technion R&D Foundation 03/18/2013 I6 (TE06) (see details) 0206 Technion R&D foundation Technion R&D Foundation 03/18/2013 HS799; disease-specific mutation (see details) 0207 Karolinska Institute Karolinska Institute 03/18/2013 UM57-1 PGD; disease-specific mutation (see details) 0208 Gary D. Smith/University of Michigan University of Michigan 03/26/2013 UM22-2 (see details) 0209 Gary D. Smith/University of Michigan University of Michigan 03/26/2013 CR-4 (see details) 0210 Rick A. Wetsel, Ph.D. University of Texas Hlth Sci Ctr at Houston 05/29/2013 WCMC-37; disease-specific mutation (see details) 0211 Weill Cornell Medical College- Nikica Zaninovic, PhD and Zev Rosenwaks, MD Joan & Sanford I. Weill Medical College of Cornell University 06/27/2013 KCL011 (see details) 0212 Dusko Ilic, King's College London King's College London 09/19/2013 KCL012; disease-specific mutation (see details) 0213 Dusko Ilic, King's College London King's College London 09/19/2013 KC013; disease-specific mutation (see details) 0214 Dusko Ilic, King's College London King's College London 09/19/2013 KCL015; disease-specific mutation (see details) 0215 Dusko Ilic, King's College London King's College London 09/19/2013 KCL016; disease-specific mutation (see details) 0216 Dusko Ilic, King's College London King's College London 09/19/2013 KCL017; disease-specific mutation (see details) 0217 Dusko Ilic, King's College London King's College London 09/19/2013 KCL018; disease-specific mutation (see details) 0218 Dusko Ilic, King's College London King's College London 09/19/2013 KCL021; disease-specific mutation (see details) 0219 Dusko Ilic, King's College London King's College London 09/19/2013 KCL024; disease-specific mutation (see details) 0220 Dusko Ilic, King's College London King's College London 09/19/2013 KCL025; disease-specific mutation (see details) 0221 Dusko Ilic, King's College London King's College London 09/19/2013 KCL026; disease-specific mutation (see details) 0222 Dusko Ilic, King's College London King's College London 09/19/2013 KCL027; disease-specific mutation (see details) 0223 Dusko Ilic, King's College London King's College London 09/19/2013 KCL028; disease-specific mutation (see details) 0224 Dusko Ilic, King's College London King's College London 09/19/2013 KCL029; disease-specific mutation (see details) 0225 Dusko Ilic, King's College London King's College London 09/19/2013 KCL030; disease-specific mutation (see details) 0226 Dusko Ilic, King's College London King's College London 09/19/2013 KCL035; disease-specific mutation (see details) 0227 Dusko Ilic, King's College London King's College London 09/19/2013 GENEA015 (see details) 0228 Genea Biocells Genea Biocells 09/30/2013 GENEA016 (see details) 0229 Genea Biocells Genea Biocells 09/30/2013 GENEA047 (see details) 0230 Genea Biocells Genea Biocells 09/30/2013 GENEA042 (see details) 0231 Genea Biocells Genea Biocells 09/30/2013 GENEA043 (see details) 0232 Genea Biocells Genea Biocells 09/30/2013 GENEA057 (see details) 0233 Genea Biocells Genea Biocells 09/30/2013 GENEA052 (see details) 0234 Genea Biocells Genea Biocells 09/30/2013 NYUES12 (see details) 0235 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 NYUES11; abnormal karyotype (see details) 0236 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 NYUES13 (see details) 0237 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 NYUES8 (see details) 0238 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 NYUES9 (see details) 0239 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 NYUES10 (see details) 0240 Christoph Hansis, MD, PhD New York University School of Medicine 12/23/2013 KCL036; disease-specific mutation (see details) 0241 Dusko Ilic, King's College London King's College London 12/23/2013 KCL042; disease-specific mutation (see details) 0242 Dusko Ilic, King's College London King's College London 12/23/2013 KCL043; disease-specific mutation (see details) 0243 Dusko Ilic, King's College London King's College London 12/23/2013 GENEA096; disease-specific mutations (see details) 0244 Genea Biocells Genea Biocells 01/29/2014 GENEA090; disease-specific mutations (see details) 0245 Genea Biocells Genea Biocells 01/29/2014 GENEA091; disease-specific mutations (see details) 0246 Genea Biocells Genea Biocells 01/29/2014 GENEA089; disease-specific mutations (see details) 0247 Genea Biocells Genea Biocells 01/29/2014 GENEA097; disease-specific mutations (see details) 0248 Genea Biocells Genea Biocells 01/29/2014 GENEA098; disease-specific mutations (see details) 0249 Genea Biocells Genea Biocells 01/29/2014 GENEA085 ; disease-specific mutation (see details) 0250 Genea Biocells Genea Biocells 01/29/2014 GENEA082 ; disease-specific mutation, abnormal karyotype (see details) 0251 Genea Biocells Genea Biocells 01/29/2014 GENEA078 ; disease-specific mutation (see details) 0252 Genea Biocells Genea Biocells 01/29/2014 GENEA079 ; disease-specific mutation (see details) 0253 Genea Biocells Genea Biocells 01/29/2014 GENEA080 ; disease-specific mutation (see details) 0254 Genea Biocells Genea Biocells 01/29/2014 GENEA081 ; disease-specific mutation (see details) 0255 Genea Biocells Genea Biocells 01/29/2014 GENEA083; disease-specific mutations, abnormal karyotype (see details) 0256 Genea Biocells Genea Biocells 01/29/2014 GENEA084 ; disease-specific mutation (see details) 0257 Genea Biocells Genea Biocells 01/29/2014 GENEA086 ; disease-specific mutation (see details) 0258 Genea Biocells Genea Biocells 01/29/2014 GENEA087 ; disease-specific mutation (see details) 0259 Genea Biocells Genea Biocells 01/29/2014 GENEA088 ; disease-specific mutation (see details) 0260 Genea Biocells Genea Biocells 01/29/2014 GENEA077; disease-specific mutation (see details) 0261 Genea Biocells Genea Biocells 01/29/2014 KCL023 (see details) 0262 Dusko Ilic, King's College London King's College London 03/25/2014 KCL031 (see details) 0263 Dusko Ilic, King's College London King's College London 03/25/2014 KCL022 (see details) 0264 Dusko Ilic, King's College London King's College London 03/25/2014 KCL038 (see details) 0265 Dusko Ilic, King's College London King's College London 03/25/2014 KCL032 (see details) 0266 Dusko Ilic, King's College London King's College London 03/25/2014 KCL033 (see details) 0267 Dusko Ilic, King's College London King's College London 03/25/2014 KCL034 (see details) 0268 Dusko Ilic, King's College London King's College London 03/25/2014 KCL037 (see details) 0269 Dusko Ilic, King's College London King's College London 03/25/2014 KCL019 (see details) 0270 Dusko Ilic, King's College London King's College London 03/25/2014 KCL020 (see details) 0271 Dusko Ilic, King's College London King's College London 03/25/2014 KCL040 (see details) 0272 Dusko Ilic, King's College London King's College London 03/25/2014 KCL041; abnormal karyotype/disease-specific mutation (see details) 0273 Dusko Ilic, King's College London King's College London 03/25/2014 KCL039 (see details) 0274 Dusko Ilic, King's College London King's College London 03/25/2014 UM59-2 PGD; disease-specific mutation (see details) 0275 Gary D. Smith/University of Michigan University of Michigan 04/09/2014 UM89-1 PGD; disease-specific mutation (see details) 0276 Gary D. Smith/University of Michigan University Of Michigan 04/09/2014 UM63-1 (see details) 0277 Gary D. Smith/University of Michigan University of Michigan 04/09/2014 UM77-2 (see details) 0278 Gary D. Smith / University of Michigan University of Michigan 04/09/2014 UM33-4 (see details) 0279 Gary D. Smith / University of Michigan University of Michigan 04/09/2014 HUES 75 (see details) 0280 Eggan Lab Harvard University 07/31/2014 HUES 71 (see details) 0281 Eggan Lab Harvard University 07/31/2014 HUES 72 (see details) 0282 Eggan Lab Harvard University 07/31/2014 HUES 73 (see details) 0283 Eggan Lab Harvard University 07/31/2014 CSC14 (see details) 0284 NeoStem, Inc. (Irvine) NeoStem, Inc. 09/18/2014 UM112-1 PGD; disease-specific mutation (see details) 0285 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM134-1 PGD; disease-specific mutation (see details) 0286 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM90-12 PGS; abnormal karyotype (see details) 0287 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM78-2 (see details) 0288 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM76-1 PGS; abnormal karyotype (see details) 0289 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM114-10 (see details) 0290 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM121-7 (see details) 0291 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UM139-2 PGD; disease-specific mutation (see details) 0292 Gary D. Smith / University of Michigan University of Michigan 09/29/2014 UCLA 13 (see details) 0293 Steven Peckman University of California, Los Angeles 10/16/2014 UCLA 14 (see details) 0294 Steven Peckman University of California, Los Angeles 10/16/2014 UCLA 15 (see details) 0295 Steven Peckman University of California, Los Angeles 10/16/2014 UCLA 16 (see details) 0296 Steven Peckman University of California, Los Angeles 10/16/2014 UCLA 17 (see details) 0297 Steven Peckman University of California, Los Angeles 10/16/2014 UCLA 18 (see details) 0298 Steven Peckman University of California, Los Angeles 10/16/2014 WIN-1 (see details) 0299 Whitehead Institute for Biomedical Research/Maisam Mitalipova Whitehead Institute for Biomedical Research 10/16/2014 WIN-2 (see details) 0300 Whitehead Institute for Biomedical Research/Maisam Mitalipova Whitehead Institute for Biomedical Research 10/16/2014 WIN-3 (see details) 0301 Whitehead Institute for Biomedical Research/Maisam Mitalipova Whitehead Institute for Biomedical Research 10/16/2014 WIN-4 (see details) 0302 Whitehead Institute for Biomedical Research/Maisam Mitalipova Whitehead Institute for Biomedical Research 10/16/2014 WIN-5 (see details) 0303 Whitehead Institute for Biomedical Research/Maisam Whitehead Institute for Biomedical Research 10/16/2014 HUES 74 (see details) 0304 Eggan Lab Harvard University 04/02/2015 UM25-2 (see details) 0305 Gary D. Smith / University of Michigan University of Michigan 04/02/2015 UM90-14 PGD; disease-specific mutation (see details) 0306 Gary D. Smith/ University of Michigan University of Michigan 04/02/2015 UM112-2 PGD; disease-specific mutation (see details) 0307 Gary D. Smith/ University of Michigan University of Michigan 04/02/2015

View original post here:
NIH Human Embryonic Stem Cell Registry - Research Using ...

Related Posts